| __timestamp | Iovance Biotherapeutics, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2704597 | 79838000 |
| Thursday, January 1, 2015 | 15470000 | 121816000 |
| Friday, January 1, 2016 | 28037000 | 117633000 |
| Sunday, January 1, 2017 | 71615000 | 117456000 |
| Monday, January 1, 2018 | 99828000 | 171984000 |
| Tuesday, January 1, 2019 | 166023000 | 257452000 |
| Wednesday, January 1, 2020 | 201727000 | 477643000 |
| Friday, January 1, 2021 | 259039000 | 540684000 |
| Saturday, January 1, 2022 | 294781000 | 651496000 |
| Sunday, January 1, 2023 | 344077000 | 666563000 |
In pursuit of knowledge
In the competitive world of biotechnology, innovation is the lifeblood of progress. Over the past decade, PTC Therapeutics, Inc. and Iovance Biotherapeutics, Inc. have been at the forefront of this innovation race, significantly increasing their research and development (R&D) spending.
From 2014 to 2023, PTC Therapeutics has consistently outpaced Iovance in R&D investment, with a staggering 735% increase, reaching over $666 million by 2023. Meanwhile, Iovance has shown impressive growth, with a 12,600% increase, culminating in $344 million in 2023.
This substantial investment in R&D underscores the commitment of both companies to pioneering new treatments and therapies. As they continue to push the boundaries of medical science, their financial dedication to innovation is a testament to their roles as leaders in the biotech industry.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
R&D Spending Showdown: Zoetis Inc. vs Iovance Biotherapeutics, Inc.
GSK plc vs PTC Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Biogen Inc. vs Iovance Biotherapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bio-Techne Corporation and PTC Therapeutics, Inc.
R&D Insights: How Sarepta Therapeutics, Inc. and PTC Therapeutics, Inc. Allocate Funds
Research and Development Investment: Halozyme Therapeutics, Inc. vs PTC Therapeutics, Inc.
R&D Insights: How Apellis Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Perrigo Company plc
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Iovance Biotherapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Iovance Biotherapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?